Natalie Raber
Adult Health · Canton, OHNPI 1366083313
Payments from drug & device makers
Across 31 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$182
- Daiichi Sankyo Inc.$48
- Johnson & Johnson$42
- AbbVie$40
- Merck$36
- Deciphera Pharmaceuticals Inc.$32
- plus $240 from 13 others
What the payments were for
- Food & beverage$621100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 8 | $182 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Johnson & Johnson | 2 | $42 |
| AbbVie | 2 | $40 |
| Merck | 2 | $36 |
| Deciphera Pharmaceuticals Inc. | 2 | $32 |
| GSK | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Mirati Therapeutics, Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $20 |
| Sanofi | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Taiho Oncology, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$621 in reported general payments places this provider in the 60th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Morphine Sulfate ErMorphine Sulfate | 129 | $3,660 |
| Ondansetron Hcl | 33 | $3,368 |
| Lidocaine | 25 | $2,892 |
| Oxycodone Hcl | 64 | $2,314 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $1,608 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 48 | $1,483 |
| Morphine Sulfate | 28 | $1,320 |
| Hydromorphone Hcl | 23 | $1,192 |
| Pregabalin | 34 | $996 |
| Megestrol Acetate | 18 | $758 |
| Methadone Hcl | 21 | $733 |
| Gabapentin | 65 | $718 |
| Tizanidine Hcl | 21 | $686 |
| Tramadol Hcl | 22 | $364 |
| Prochlorperazine Maleate | 12 | $286 |
Paid to pharmacies, not to this prescriber.
Other adult health in Canton
- Bonnie MohlerCanton$338K
- Courtney Ray-MartyCanton$16K
- Kristen BurockCanton$8K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
- Teresa ShafferBoardman$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.